Cholangiocarcinomas Recruiting Phase 2 Trials for Copanlisib (DB12483)

Also known as: Cholangiocarcinoma / Cholangiocarcinoma NOS / Cholangiocarcinoma of biliary tract

IndicationStatusPhase
DBCOND0051818 (Cholangiocarcinomas)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02631590Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced CholangiocarcinomaTreatment